Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Prostate cancer screening practices examined

16.03.2005


Initial results from an ongoing study evaluating the benefit of prostate cancer screening practices demonstrate that the combined use of both standard tests--the prostate-specific antigen (PSA) blood test and the digital rectal exam (DRE)--is optimal for detecting cancer.



The initial results also confirm that the design of the massive study, which will continue until 2019, will indeed allow researchers to determine whether current screening practices reduce death from prostate cancer, according to the authors. They present their analyses in two papers, one in the March 16 issue of the Journal of the National Cancer Institute and the other in the March issue of the Journal of Urology.

The study is part of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial being conducted by researchers at Washington University School of Medicine in St. Louis and several other institutions.


Uncertainty about the need for prostate cancer screens stems from several factors. PSA and DRE tests can be inaccurate, giving both false negatives and false positives. In addition, neither test indicates how aggressive a man’s cancer is. Furthermore, because prostate cancers grow slowly in many cases and treatments can have unpleasant side effects, treating the cancer may be less desirable than leaving it alone, especially in older men.

"But the main thing is we don’t know whether screening saves lives," says Gerald L. Andriole Jr., M.D., head of the Division of Urologic Surgery at Washington University and Barnes-Jewish Hospital. "Our study follows about 75,000 men, half of whom we are screening, and half of whom are getting conventional care. By comparing groups over the long term, we will see what difference screening makes in survival rates."

Begun in 1993, the PLCO study has screened 34,244 men across the United States, aged 55 to 74, for prostate cancer and followed their subsequent medical history. The PLCO protocol advises men to consult their own physician if either the PSA or DRE tests given by PLCO are suggestive of cancerous growth.

The outcome of the study should aid patients and doctors in making decisions about diagnosis and treatment of prostate cancer. "It’s a complex decision," Andriole explains. "Say your father had an abnormal PSA test, and he’s 76 and has a bad heart, diabetes, or recently had a stroke. Frankly, the patient and doctor have to base their decision on the probability that one of those factors may cause death before prostate cancer."

Of the men screened by PLCO, about 14 percent had positive screening results, indicative of possible cancer. Approximately 8 percent screened positive by PSA test, and about 7 percent screened positive by DRE test. Only about 1 percent of these results overlapped, demonstrating the importance of using both screening methods.

"We were hopeful some years ago that men could just have the PSA blood test, because men hate the rectal exam," Andriole says. "We’ve found that if you omit the DRE, you’ll miss a certain percentage of cancers."

Three-fourths of the men with positive PLCO screens went in for further diagnostic evaluation with their personal physician. The physicians would decide whether to conduct their own screenings and whether to subsequently perform a biopsy, which is needed to confirm the presence of cancer before treatment.

About a third of men with abnormal tests had a prostatic biopsy within a year of the initial screen. Of men with PSA readings higher than normal, 64 percent underwent biopsy within three years. The higher the PSA readings, the higher the biopsy rates. The biopsy rate in men with positive DRE alone was 28 percent.

The initial data indicate that younger men, men with a family history of prostate cancer and African American men are more likely to have a biopsy after an abnormal screening result. "These statistics parallel many medical recommendations and reassure us that good judgment is being applied to the evaluation of the initial screen," Andriole says. "We are confident that when the study is ultimately completed, it will truly measure the effect of current medical practices."

In men with suspicious PSA readings, regardless of DRE findings, biopsy revealed cancer almost half the time, while in men with suspicious DRE tests, regardless of PSA levels, biopsy found cancer about a third of the time.

The majority of men with cancer had localized cancers. About ten percent had more serious advanced forms. These advanced cancers were linked to higher PSA numbers and suspicious DRE results.

Overall, 1.4 percent of the approximately 34,000 men screened were subsequently diagnosed with prostate cancer by tissue biopsy. This rate of detection is lower than in two previous studies of prostate cancer screening, which found cancer in 4.2 and 3.2 percent of patients, respectively.

This lower rate of detection more accurately reflects the contemporary standards of practice, because biopsy and diagnosis took place outside of the PLCO study, according to the authors.

Gwen Ericson | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>